Squarepoint’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,700
Closed -$2.79M 5223
2024
Q4
$2.79M Sell
10,700
-1,100
-9% -$277K ﹤0.01% 2114
2024
Q3
$2.75M Buy
11,800
+4,300
+57% +$883K ﹤0.01% 1844
2024
Q2
$1.51M Sell
7,500
-15,400
-67% -$2.78M ﹤0.01% 2255
2024
Q1
$3.93M Buy
+22,900
New +$4.27M 0.01% 1633
2023
Q4
Sell
-2,100
Closed -$335K 4384
2023
Q3
$335K Buy
2,100
+100
+5% +$22.4K ﹤0.01% 3082
2023
Q2
$577K Buy
+2,000
New +$607K ﹤0.01% 2530

Other funds holding PODD

Squarepoint's PODD Position: Q2 2026 in Review

Squarepoint increased its Insulet (PODD) stake by 1,156% in Q2 2026, buying an estimated $41M and bringing the position to 267,642 shares worth $40.7M. The position accounts for 0.05% of the portfolio, ranked #405.

Squarepoint first reported a position in PODD in Q2 2017 and has held it in 32 quarters since. The position peaked at $70.2M in Q3 2025. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Squarepoint held 267,642 shares of Insulet worth $40.7M as of Q2 2026.
  • Squarepoint bought 246,331 Insulet shares in Q2 2026, an estimated $41M.
  • Insulet made up 0.05% of Squarepoint's portfolio in Q2 2026, its #405 holding.
  • Squarepoint first reported a position in Insulet in Q2 2017 and has held it in 32 quarters since.
  • Squarepoint's Insulet position peaked at $70.2M in Q3 2025.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.